What is the share price of Nexus Surgical and Medicare Ltd (NEXUSSURGL) today?

The share price of NEXUSSURGL as on 25th September 2026 is ₹30.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?

The past returns of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share are Past 1 week: -7.58%Past 1 month: 57.38%Past 3 months: 57.76%Past 6 months: 87.31%Past 1 year: 60.21%Past 3 years: 159.41%Past 5 years: 987.72%

What are the peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL)?

The peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL) include: Nexus Surgical and Medicare Ltd Sun Pharmaceutical Industries Ltd Torrent Pharmaceuticals Ltd Zydus Lifesciences Ltd Cipla Ltd Laurus Labs Ltd

What is the market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹17.48 Cr as of 25th September 2026.

What is the 52 week high and low of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?

The 52-week high of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹35.79 and the 52-week low is ₹13.26.

What is the PE and PB ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) stock?

The P/E (price-to-earnings) ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is 23.00. The P/B (price-to-book) ratio is 9.71.

Which sector does Nexus Surgical and Medicare Ltd (NEXUSSURGL) belong to?

Nexus Surgical and Medicare Ltd (NEXUSSURGL) belongs to the Health Care sector & Pharmaceuticals sub-sector.

How to buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares?

You can directly buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Nexus Surgical and Medicare Ltd

NEXUSSURGL Share Price

BSE

₹30.504.54% (-1.45)

Health Care

Pharmaceuticals Globe Capital Market Portfolio

Smallcap

With a market cap of ₹17 cr, stock is ranked 4,713

High Risk

Stock is 6.58x as volatile as Nifty

NEXUSSURGL Stock Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals Globe Capital Market Portfolio

Smallcap

With a market cap of ₹17 cr, stock is ranked 4,713

High Risk

Stock is 6.58x as volatile as Nifty

NEXUSSURGL Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
21.58	9.71	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
47.49	5.95	0.48%

NEXUSSURGL Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

NEXUSSURGL Company Profile

Nexus Surgical and Medicare Limited is an India-based company engaged in the trading of surgical and pharmaceutical products. It imports and markets a range of medical supplies, including disposable syringes and sterilization pouches.

NEXUSSURGL Similar Stocks (Peers)

Compare with peers Compare with peers

NEXUSSURGL Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

38.67

1Y Return

13.81%

Buy Reco %

93.33

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

86.65

1Y Return

41.25%

Buy Reco %

81.48

Zydus Lifesciences Ltd

ZYDUSLIFE

PE Ratio

23.36

1Y Return

18.12%

Buy Reco %

55.56

Cipla Ltd

CIPLA

PE Ratio

29.13

1Y Return

7.29%

Buy Reco %

62.86

Laurus Labs Ltd

LAURUSLABS

PE Ratio

123.18

1Y Return

123.91%

Buy Reco %

58.33

Compare with Peers

NEXUSSURGL Forecast

NEXUSSURGL Forecasts

NEXUSSURGL

Income

Balance Sheet

Cash Flow

Financial Year		FY 2018		FY 2019		FY 2020		FY 2021		FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	TTM
Total Revenue	1.04	2.22	1.73	3.75	2.42	1.56	3.50	5.73	7.90	8.76
Raw Materials	0.89	2.09	0.78	1.02	0.43	0.10	0.93	1.90	2.38	7.68
Power & Fuel Cost	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Employee Cost	0.22	0.09	0.15	0.32	0.22	0.25	0.24	0.41	0.32
Selling & Administrative Expenses	0.11	0.08	0.69	2.24	1.77	0.60	2.17	2.16	3.57
Operating & Other expenses	0.13	0.05	5.39	-0.01	-0.39	0.38	-0.13	0.58	0.61
EBITDA	-0.32	-0.09	-5.28	0.18	0.39	0.23	0.29	0.68	1.02	1.08
Depreciation/Amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBIT	-0.32	-0.09	-5.28	0.18	0.39	0.23	0.29	0.68	1.02	1.08
Interest & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.00
PBT	-0.32	-0.09	-5.28	0.18	0.39	0.23	0.28	0.67	1.01	1.08
Taxes & Other Items	0.01	0.00	0.02	0.01	0.10	0.06	0.08	0.17	0.25	0.27
Net Income	-0.33	-0.09	-5.30	0.17	0.29	0.17	0.20	0.50	0.76	0.81
EPS	-0.60	-0.16	-9.69	0.31	0.53	0.31	0.37	0.91	1.39	1.48
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

NEXUSSURGL Income Statement

Quarter		mar 2024		jun 2024		sep 2024		dec 2024		mar 2025	jun 2025	sep 2025	dec 2025	mar 2026	jun 2026
Total Revenue	0.59	1.76	0.99	1.48	1.49	1.73	1.17	2.94	2.07	2.58
Operating & Other expenses	0.51	1.64	0.72	1.33	1.37	1.52	0.93	2.70	1.75	2.30
EBITDA	0.08	0.12	0.27	0.15	0.12	0.21	0.24	0.24	0.32	0.28
Depreciation/Amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBIT	0.08	0.12	0.27	0.15	0.12	0.21	0.24	0.24	0.32	0.28
Interest & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBT	0.08	0.12	0.27	0.15	0.12	0.21	0.24	0.24	0.32	0.28
Taxes & Other Items	0.02	0.03	0.07	0.04	0.03	0.05	0.06	0.06	0.08	0.07
Net Income	0.06	0.09	0.20	0.11	0.09	0.16	0.18	0.18	0.24	0.21
EPS	0.11	0.16	0.38	0.21	0.16	0.28	0.32	0.31	0.44	0.37

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Cash from Operating Activities	-0.17	-0.07	0.02	0.24	0.20	-0.11	0.55	-0.41	0.10	0.17
Cash from Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	-0.01	0.00
Cash from Financing Activities	0.20	-0.04	0.01	-0.26	0.00	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	+0.03	-0.11	+0.03	-0.02	+0.20	-0.11	+0.54	-0.41	+0.09	+0.17
Changes in Working Capital	+0.03	+0.25	+0.12	+0.17	+0.03	-0.51	+0.32	-0.71	-0.58	-0.82
Capital Expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00
Free Cash Flow	-0.17	-0.07	0.02	0.24	0.20	-0.11	0.54	-0.41	0.09	0.17

NEXUSSURGL Company Updates

FY 2026FY 2026

Annual report

PDF

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

NEXUSSURGL Stock Peers

NEXUSSURGL Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Nexus Surgical and Medicare Ltd	23.00	9.71	—
Sun Pharmaceutical Industries Ltd	38.67	5.29	0.86%
Torrent Pharmaceuticals Ltd	86.65	10.66	0.69%
Zydus Lifesciences Ltd	23.36	3.98	0.09%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Nexus Surgical and Medicare Ltd	Pro
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Nexus Surgical and Medicare Ltd	87.59%	58.17	Pro
Sun Pharmaceutical Industries Ltd	20.02%	35.70
Torrent Pharmaceuticals Ltd	22.58%	51.56
Zydus Lifesciences Ltd	23.61%	59.25

NEXUSSURGL Stock Price Comparison

Compare NEXUSSURGL with any stock or ETF

NEXUSSURGL

NEXUSSURGL Holdings

NEXUSSURGL Shareholdings

NEXUSSURGL Promoter Holdings Trend

NEXUSSURGL Institutional Holdings Trend

NEXUSSURGL Shareholding Pattern

NEXUSSURGL Shareholding History

Foreign Institutions

NEXUSSURGL Insider Trades & Bulk Stock Deals

smallcases containing NEXUSSURGL stock

Looks like this stock is not in any smallcase yet.

NEXUSSURGL Events

NEXUSSURGL Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

NEXUSSURGL Dividend Trend

NEXUSSURGL Dividends

Hmm, looks like data is unavailable here. Please come back after some time

NEXUSSURGL Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

AGM/EGM

Announced OnSep 25, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Sep 25, 2026

Company Update

Announced OnSep 3, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Sep 3, 2026

Others

Announced OnSep 3, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Sep 3, 2026

AGM/EGM

Announced OnSep 3, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Sep 3, 2026

AGM/EGM

Announced OnSep 2, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Sep 2, 2026

NEXUSSURGL Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

NEXUSSURGL Stock News & Opinions

Corporate

Nexus Surgical appoints Anish More as Managing Director for three years, effective September 2026

Nexus Surgical and Medicare Limited announced the appointment of Mr. Anish More (DIN 11070098) as an Additional Director (Executive) effective September 2, 2026, and proposed his appointment as Managing Director for a three-year term from September 2, 2026, to September 1, 2029, subject to shareholder approval at the company’s 35th Annual General Meeting; Mr. More will receive an annual remuneration of Rs 24,00,000, subject to member approval.

3 weeks agoCapital Market - Live

Corporate

Ram Swaroop Joshi resigns as Managing Director of Nexus Surgical, effective September 2026

Nexus Surgical and Medicare Limited announced that Ram Swaroop Joshi has resigned as Managing Director, effective September 2, 2026, due to personal reasons. Joshi, who served as Managing Director since 2022, will continue as a Promoter Non-Executive Director of the company.

3 weeks agoCapital Market - Live

Corporate

Nexus Surgical’s board will convene September 2 to review financials and AGM details

Nexus Surgical and Medicare Limited will hold a board meeting on September 2, 2026, at 3:00 p.m. at its registered office to approve the directors' report and audited financial statements for the financial year ended March 31, 2026, and to address matters including the date and time of the 35th Annual General Meeting, register closure, e-voting cut-off date, and appointment of a scrutinizer.

1 month agoCapital Market - Live

Corporate

Nexus Surgical to review quarterly results at board meeting on August 13, 2026

Nexus Surgical and Medicare Limited will hold a board meeting on Thursday, August 13, 2026, at 4:00 p.m. to consider and approve the unaudited quarterly financial results for the quarter ended June 30, 2026, according to a filing with the BSE Limited. The trading window for dealing in securities for designated persons will remain closed until August 15, 2026.

1 month agoCapital Market - Live

Earnings

Nexus Surgical and Medicare standalone net profit rises 166.67% in the March 2026 quarter

Net profit of Nexus Surgical and Medicare rose 166.67% to Rs 0.24 crore in the quarter ended March 2026 as against Rs 0.09 crore during the previous quarter ended March 2025. Sales rose 38.51% to Rs 2.05 crore in the quarter ended March 2026 as against Rs 1.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 48.00% to Rs 0.74 crore in the year ended March 2026 as against Rs 0.50 crore during the previous year ended March 2025. Sales rose 37.59% to Rs 7.87 crore in the year ended March 2026 as against Rs 5.72 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2.051.48 39 7.875.72 38 OPM %14.637.43 -12.2011.54 - PBDT0.320.12 167 0.990.67 48 PBT0.320.12 167 0.990.67 48 NP0.240.09 167 0.740.50 48 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to discuss results

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 28 May 2026.

4 months agoCapital Market - Live

Earnings

Nexus Surgical and Medicare standalone net profit rises 54.55% in the December 2025 quarter

Net profit of Nexus Surgical and Medicare rose 54.55% to Rs 0.17 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024. Sales rose 97.97% to Rs 2.93 crore in the quarter ended December 2025 as against Rs 1.48 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2.931.48 98 OPM %7.5110.14 - PBDT0.230.15 53 PBT0.230.15 53 NP0.170.11 55 Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to announce Quarterly Result

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Nexus Surgical and Medicare standalone net profit declines 19.05% in the September 2025 quarter

Net profit of Nexus Surgical and Medicare declined 19.05% to Rs 0.17 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024. Sales rose 18.18% to Rs 1.17 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1.170.99 18 OPM %19.6628.28 - PBDT0.230.28 -18 PBT0.230.28 -18 NP0.170.21 -19 Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to discuss results

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

What is the share price of Nexus Surgical and Medicare Ltd (NEXUSSURGL) today?
The share price of NEXUSSURGL as on 25th September 2026 is ₹30.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The past returns of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share are
- Past 1 week: -7.58%
- Past 1 month: 57.38%
- Past 3 months: 57.76%
- Past 6 months: 87.31%
- Past 1 year: 60.21%
- Past 3 years: 159.41%
- Past 5 years: 987.72%
What are the peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL)?
The peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL) include:
What is the market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹17.48 Cr as of 25th September 2026.
What is the 52 week high and low of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The 52-week high of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹35.79 and the 52-week low is ₹13.26.
What is the PE and PB ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) stock?
The P/E (price-to-earnings) ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is 23.00. The P/B (price-to-book) ratio is 9.71.
Which sector does Nexus Surgical and Medicare Ltd (NEXUSSURGL) belong to?
Nexus Surgical and Medicare Ltd (NEXUSSURGL) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares?
You can directly buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares on Tickertape. Simply sign up, connect your demat account and place your order.